• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与严重复杂性艰难梭菌感染发展相关的临床因素。

Clinical factors associated with development of severe-complicated Clostridium difficile infection.

机构信息

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

出版信息

Clin Gastroenterol Hepatol. 2013 Nov;11(11):1466-71. doi: 10.1016/j.cgh.2013.04.050. Epub 2013 May 20.

DOI:10.1016/j.cgh.2013.04.050
PMID:23702192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3846768/
Abstract

BACKGROUND & AIMS: Clostridium difficile infection (CDI) can cause life-threatening complications. Severe-complicated CDI is characterized by hypotension, shock, sepsis, ileus, megacolon, and colon perforation. We created a model to identify clinical factors associated with severe-complicated CDI.

METHODS

We analyzed data from 1446 inpatient cases of CDI (48.6% female; median age, 62.5 years; range, 0.1-103.7 years) at the Mayo Clinic from June 28, 2007, to June 25, 2010. Patients with severe-complicated CDI (n = 487) were identified as those who required admission to the intensive care unit or colectomy, or died, within 30 days of CDI diagnosis. Logistic regression models were used to identify variables that were independently associated with the occurrence of severe-complicated CDI in 2 cohorts. One cohort comprised all hospitalized patients; the other comprised a subset of these inpatients who were residents of Olmsted County, Minnesota to assess the association of comorbid conditions with the development of severe-complicated infection in a population-based cohort. The linear combinations of variables identified by using logistic regression models provided scores to predict the risk of developing severe-complicated CDI.

RESULTS

In a multivariable model that included all inpatients, increasing age, leukocyte count >15 × 10(9)/L, increase in serum level of creatinine >1.5-fold from baseline, and use of proton pump inhibitors or narcotic medications were independently associated with severe-complicated CDI. In the secondary analysis, which included only patients from Olmsted County, comorbid conditions were not significantly associated with severe-complicated CDI.

CONCLUSIONS

Older age, high numbers of leukocytes in blood samples, an increased serum level of creatinine, gastric acid suppression, and use of narcotic medications were independently associated with development of severe-complicated CDI in hospitalized patients. Early aggressive monitoring and intervention could improve outcomes.

摘要

背景与目的

艰难梭菌感染(CDI)可导致危及生命的并发症。严重复杂性 CDI 的特征为低血压、休克、败血症、肠梗阻、巨结肠和结肠穿孔。我们创建了一个模型来确定与严重复杂性 CDI 相关的临床因素。

方法

我们分析了 2007 年 6 月 28 日至 2010 年 6 月 25 日梅奥诊所 1446 例住院 CDI 患者(48.6%为女性;中位年龄 62.5 岁;范围 0.1-103.7 岁)的数据。严重复杂性 CDI(n=487)患者定义为 CDI 诊断后 30 天内需入住重症监护病房或接受结肠切除术或死亡的患者。使用逻辑回归模型确定 2 个队列中与严重复杂性 CDI 发生独立相关的变量。一个队列包括所有住院患者;另一个队列包括明尼苏达州奥姆斯特德县的这些住院患者子集,以评估在基于人群的队列中合并症与严重感染发生的相关性。逻辑回归模型确定的变量线性组合提供了预测发生严重复杂性 CDI 的风险评分。

结果

在包括所有住院患者的多变量模型中,年龄增加、白细胞计数>15×10(9)/L、血清肌酐水平从基线增加 1.5 倍以上、使用质子泵抑制剂或麻醉药物与严重复杂性 CDI 独立相关。在仅包括奥姆斯特德县患者的二次分析中,合并症与严重复杂性 CDI 无显著相关性。

结论

在住院患者中,年龄较大、血液白细胞计数较高、血清肌酐水平升高、胃酸抑制和使用麻醉药物与严重复杂性 CDI 的发生独立相关。早期积极监测和干预可能改善结局。

相似文献

1
Clinical factors associated with development of severe-complicated Clostridium difficile infection.与严重复杂性艰难梭菌感染发展相关的临床因素。
Clin Gastroenterol Hepatol. 2013 Nov;11(11):1466-71. doi: 10.1016/j.cgh.2013.04.050. Epub 2013 May 20.
2
Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study.胃酸抑制与艰难梭菌感染结局的关系:基于人群的研究。
Mayo Clin Proc. 2012 Jul;87(7):636-42. doi: 10.1016/j.mayocp.2011.12.021.
3
Clinical predictors of recurrent Clostridium difficile infection in out-patients.门诊患者复发性艰难梭菌感染的临床预测因素
Aliment Pharmacol Ther. 2014 Sep;40(5):518-22. doi: 10.1111/apt.12864. Epub 2014 Jul 10.
4
Outcomes in community-acquired Clostridium difficile infection.社区获得性艰难梭菌感染的结局。
Aliment Pharmacol Ther. 2012 Mar;35(5):613-8. doi: 10.1111/j.1365-2036.2011.04984.x. Epub 2012 Jan 10.
5
Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.核酸扩增试验阳性/毒素酶免疫测定阴性患者中艰难梭菌感染相关并发症及治疗模式的预测因素。
J Clin Microbiol. 2020 Feb 24;58(3). doi: 10.1128/JCM.01764-19.
6
Poor functional status as a risk factor for severe Clostridium difficile infection in hospitalized older adults.较差的功能状态是导致住院老年患者发生严重艰难梭菌感染的一个危险因素。
J Am Geriatr Soc. 2013 Oct;61(10):1738-42. doi: 10.1111/jgs.12442. Epub 2013 Sep 19.
7
Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.系统炎症介质是预测艰难梭菌感染不良结局的有效生物标志物。
mBio. 2020 May 5;11(3):e00180-20. doi: 10.1128/mBio.00180-20.
8
The epidemiology of Clostridium difficile infection in children: a population-based study.儿童艰难梭菌感染的流行病学:一项基于人群的研究。
Clin Infect Dis. 2013 May;56(10):1401-6. doi: 10.1093/cid/cit075. Epub 2013 Feb 13.
9
Clostridium difficile infection in children hospitalized due to diarrhea.儿童因腹泻住院时的艰难梭菌感染。
Eur J Clin Microbiol Infect Dis. 2014 Feb;33(2):201-9. doi: 10.1007/s10096-013-1946-1. Epub 2013 Nov 10.
10
Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.质子泵抑制剂与住院患者中复发性艰难梭菌感染的风险。
Am J Gastroenterol. 2013 Nov;108(11):1794-801. doi: 10.1038/ajg.2013.333. Epub 2013 Sep 24.

引用本文的文献

1
Impact of Acid Suppressants on the Development of Infection and Possible Preventive Effects of Probiotic Formulations.抑酸剂对感染发生的影响及益生菌制剂的潜在预防作用
Infect Drug Resist. 2025 Aug 31;18:4593-4602. doi: 10.2147/IDR.S543864. eCollection 2025.
2
Multi-omic profiling a defined bacterial consortium for treatment of recurrent Clostridioides difficile infection.对用于治疗复发性艰难梭菌感染的特定细菌群落进行多组学分析。
Nat Med. 2025 Jan;31(1):223-234. doi: 10.1038/s41591-024-03337-4. Epub 2025 Jan 2.
3
A Three-Year Analysis of Mortality in Clostridioides difficile Patients in a Tertiary Center.

本文引用的文献

1
Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study.胃酸抑制与艰难梭菌感染结局的关系:基于人群的研究。
Mayo Clin Proc. 2012 Jul;87(7):636-42. doi: 10.1016/j.mayocp.2011.12.021.
2
Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease.预测炎症性肠病患者中与艰难梭菌感染相关的严重结局的因素。
Aliment Pharmacol Ther. 2012 Apr;35(7):789-95. doi: 10.1111/j.1365-2036.2012.05022.x. Epub 2012 Feb 23.
3
An evaluation of repeat stool testing for Clostridium difficile infection by polymerase chain reaction.
三级医疗中心艰难梭菌感染患者死亡率的三年分析
Cureus. 2024 Nov 23;16(11):e74291. doi: 10.7759/cureus.74291. eCollection 2024 Nov.
4
Personalizing Prediction of High Opioid Use in the Neurointensive Care Unit: Development and Validation of a Stratified Risk Model for Acute Brain Injury Due to Stroke or Traumatic Brain Injury.个性化预测神经重症监护病房中高阿片类药物使用情况:针对中风或创伤性脑损伤所致急性脑损伤的分层风险模型的开发与验证
J Clin Med. 2024 Nov 22;13(23):7055. doi: 10.3390/jcm13237055.
5
infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options.感染:历史、流行病学、风险因素、预防、临床表现、治疗和未来选择。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0013523. doi: 10.1128/cmr.00135-23. Epub 2024 Feb 29.
6
Validation of Clinical Risk Models for Clostridioides difficileAttributable Outcomes.临床风险模型对艰难梭菌感染相关结局的验证。
Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0067622. doi: 10.1128/aac.00676-22. Epub 2022 Jun 21.
7
Fecal Microbiota Transplant in Severe and Non-Severe Infection. Is There a Role of FMT in Primary Severe CDI?粪便微生物群移植治疗重度和非重度感染。粪便微生物群移植在原发性重度艰难梭菌感染中是否起作用?
J Clin Med. 2021 Dec 13;10(24):5822. doi: 10.3390/jcm10245822.
8
Novel risk factors and outcomes in inflammatory bowel disease patients with infection.炎症性肠病合并感染患者的新型危险因素及结局
Therap Adv Gastroenterol. 2021 Mar 12;14:1756284821997792. doi: 10.1177/1756284821997792. eCollection 2021.
9
Usual opioid dosing does not adversely affect the course of healthcare-associated infection.常规阿片类药物剂量不会对医疗保健相关性感染的病程产生不良影响。
Pain Manag. 2021 Mar;11(2):151-157. doi: 10.2217/pmt-2020-0066. Epub 2020 Dec 22.
10
Gut Microbiota Composition Associated With -Positive Diarrhea and Type in ICU Patients.与 ICU 患者中艰难梭菌阳性腹泻和艰难梭菌感染相关的肠道微生物组成。
Front Cell Infect Microbiol. 2020 May 11;10:190. doi: 10.3389/fcimb.2020.00190. eCollection 2020.
对聚合酶链反应检测艰难梭菌感染重复粪便检测的评估。
J Clin Gastroenterol. 2012 Nov-Dec;46(10):846-9. doi: 10.1097/MCG.0b013e3182432273.
4
Outcomes in community-acquired Clostridium difficile infection.社区获得性艰难梭菌感染的结局。
Aliment Pharmacol Ther. 2012 Mar;35(5):613-8. doi: 10.1111/j.1365-2036.2011.04984.x. Epub 2012 Jan 10.
5
The epidemiology of community-acquired Clostridium difficile infection: a population-based study.社区获得性艰难梭菌感染的流行病学:一项基于人群的研究。
Am J Gastroenterol. 2012 Jan;107(1):89-95. doi: 10.1038/ajg.2011.398. Epub 2011 Nov 22.
6
Risk factors associated with complications and mortality in patients with Clostridium difficile infection.艰难梭菌感染患者并发症和死亡率相关的危险因素。
Clin Infect Dis. 2011 Dec;53(12):1173-8. doi: 10.1093/cid/cir668. Epub 2011 Oct 5.
7
Reducing the risk of severe complications among patients with Clostridium difficile infection.降低艰难梭菌感染患者发生严重并发症的风险。
Can J Gastroenterol. 2011 Jul;25(7):368-72. doi: 10.1155/2011/153020.
8
CSI: a severity index for Clostridium difficile infection at the time of admission.CSI:入院时艰难梭菌感染的严重程度指数。
J Hosp Infect. 2011 Oct;79(2):151-4. doi: 10.1016/j.jhin.2011.04.017. Epub 2011 Aug 17.
9
Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections. fidaxomicin 与万古霉素治疗同时使用抗生素治疗其他合并感染的个体中艰难梭菌感染的疗效。
Clin Infect Dis. 2011 Sep;53(5):440-7. doi: 10.1093/cid/cir404.
10
Serum markers for severe Clostridium difficile infection in immunosuppressed hospitalized patients.免疫抑制住院患者中严重艰难梭菌感染的血清标志物
J La State Med Soc. 2011 Mar-Apr;163(2):91-4.